A federal court this week denied a request from the U.S. Department of Health and Human Services to nix a lawsuit from drugmaker AstraZeneca over the 340B drug discount program. The court said HHS’ position that the 340B statute requires drug manufacturers to participate in the program to offer discounts on drugs dispensed by contract pharmacies, was not the only reasonable interpretation of the statute.
Judge dismisses HHS challenge of AstraZeneca’s 340B contract pharmacies lawsuit
